Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Scott Chih-Hsi,Kuo ; Ping-Chih,Hsu ; Chih-Hung,Chen ; Chih-Teng,Yu ; Chih-Liang,Wang ; Fu-Tsai,Chung ; Shu-Min,Lin ; Yu-Lun,Lo ; Tse-Ching,Chen ; Chien-Ying,Liu ; Cheng-Ta,Yang

主题词腺癌(Adenocarcinoma);抗肿瘤药(Antineoplastic Agents);无病生存(Disease-Free Survival);外显子(Exons);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);回顾性研究(Retrospective Studies);序列缺失(Sequence Deletion)

DOI 10.1159/000371735

PMID 25871639

发布时间 2019-02-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览27

Chemotherapy

2014年60卷3期

201-10页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.

Chemotherapy

相似文献

Chemotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.

Chemotherapy

相似文献

Chemotherapy

相关期刊

检索历史清除